NEMO is essential for directing the kinases IKKα and ATM to the sites of DNA damage
Science Signaling · 2025
DOI: 10.1126/scisignal.adr0128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Josune Alonso-Marañón und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Program, Hospital del Mar Research Institute, CIBERONC, Hospital del Mar, Doctor Aiguader 88, Barcelona 08003, Spain. Hauptthemen laut MEDLINE: I-kappa B Kinase, Ataxia Telangiectasia Mutated Proteins, DNA Damage, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
The DNA damage repair kinase ATM is phosphorylated by the NF-κB pathway kinase IKKα, resulting in enhanced DNA damage repair through the nonhomologous end-joining pathway. Thus, inhibition of IKKα enhances the efficacy of cancer therapy based on inducing DNA damage. Here, we found a role for the IKK regulatory subunit NEMO in DNA damage repair mediated by ATM and IKKα. Exposure to damaging agents induced the interaction of NEMO with a preformed ATM-IKKα complex, which was required to target active ATM and IKKα to chromatin for efficient DNA damage repair but not for activating ATM. Recognition of damaged DNA by the IKKα-NEMO-ATM complex was facilitated by the interaction between NEMO and histones and depended on the ADP ribosylation of histones by the enzyme PARP1. NEMO-deficient cells showed increased activity of the kinase ATR, and inhibition of ATR potentiated the effect of chemotherapy in cells lacking NEMO or IKKα. Bioinformatic analysis of colorectal cancer datasets demonstrated that the expression of genes encoding IKKα, NEMO, and ATM correlated with poor patient prognosis, suggesting that the mechanism linking these three elements may be clinically relevant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Research Program, Hospital del Mar Research Institute, CIBERONC, Hospital del Mar, Doctor Aiguader 88, Barcelona 08003, Spain.
- Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospital…
- Immunology Unit, Department of Pathology, Hospital del Mar, Barcelona 08003, Spain.
- Proteomics Unit, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona 08003, Spain.
- Proteomics Unit, Universitat Pompeu Fabra, Barcelona 08003, Spain.
- McArdle Laboratory for Cancer Research, University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Wisconsin Institutes for Medical Research, Madison, WI 53705, USA.
ORCID-Profile: Josune Alonso-Marañón, Laura Solé, Daniel Álvarez-Villanueva, María Maqueda, Teresa Lobo-Jarne, Ángela Montoto, Jose Yélamos, Eva Borràs, Eduard Sabidó, Shigeki Miyamoto, Anna Bigas
Förderung
- NCI NIH HHS
Zitieren
APA
Alonso-Marañón, J., Solé, L., Álvarez-Villanueva, D., Maqueda, M., Lobo-Jarne, T., Montoto, Á., Yélamos, J., Borràs, E., Uraga, L., Hooper, C., Sabidó, E., Miyamoto, S., Bigas, A., & Espinosa, L. (2025). NEMO is essential for directing the kinases IKKα and ATM to the sites of DNA damage. Science Signaling. https://doi.org/10.1126/scisignal.adr0128
Vancouver
Alonso-Marañón J, Solé L, Álvarez-Villanueva D, Maqueda M, Lobo-Jarne T, Montoto Á, et al. NEMO is essential for directing the kinases IKKα and ATM to the sites of DNA damage. Science Signaling. 2025. doi:10.1126/scisignal.adr0128
BibTeX
@article{AlonsoMaran2025,
author = {Alonso-Marañón, Josune and Solé, Laura and Álvarez-Villanueva, Daniel and Maqueda, María and Lobo-Jarne, Teresa and Montoto, Ángela and Yélamos, Jose and Borràs, Eva and Uraga, Leire and Hooper, Christopher and Sabidó, Eduard and Miyamoto, Shigeki and Bigas, Anna and Espinosa, Lluís},
title = {NEMO is essential for directing the kinases IKKα and ATM to the sites of DNA damage},
journal = {Science Signaling},
year = {2025},
doi = {10.1126/scisignal.adr0128}
}
EUVIMED